FeCl3-Catalyzed Synthesis of Symmetrical Pyridines from Ketoxime Acetates Using DMFDMA as an Effective C1 Synthon DOI

Rajitha Lakshmi Podugu,

Varaprasad Bodala,

Kumari Yettula

и другие.

Polycyclic aromatic compounds, Год журнала: 2023, Номер 44(7), С. 4455 - 4466

Опубликована: Сен. 7, 2023

AbstractAn efficient and facile strategy has been developed for the synthesis of symmetrical pyridines in good to excellent yields from ketoxime acetates DMFDMA presence FeCl3 at 120 °C 6 h under argon atmosphere. In this protocol, acts as an effective C1 synthon. The use inexpensive catalysts, no need additional ligands additives, functional group tolerance are perks protocol.Keywords: Symmetrical pyridinesDMFDMAoximeacetatesFeCl3C1 synthon AcknowledgmentsThe authors thank DST (Department Science & Technology), New Delhi funding through project EEQ/2021/000168.Disclosure statementNo potential conflict interest was reported by authors.

Язык: Английский

Discovery of imidazopyridine derived oxadiazole-based thiourea derivatives as potential anti-diabetic agents: Synthesis, in vitro antioxidant screening and in silico molecular modeling approaches DOI
Rafaqat Hussain, Wajid Rehman, Fazal Rahim

и другие.

Journal of Molecular Structure, Год журнала: 2023, Номер 1293, С. 136185 - 136185

Опубликована: Июль 21, 2023

Язык: Английский

Процитировано

46

Correlation between in vitro anti-urease activity and in silico molecular modeling approach of novel imidazopyridine–oxadiazole hybrids derivatives DOI Creative Commons
Shoaib Khan, Rafaqat Hussain, Yousaf Khan

и другие.

Open Chemistry, Год журнала: 2024, Номер 22(1)

Опубликована: Янв. 1, 2024

Abstract In the current era, a potent drug is still needed on market for treatment of various diseases worldwide. Researchers mainly focus those enzymes that cause these diseases. One major caused by an enzyme called urease, which increases concentration ammonia in body upon hydrolysis. across globe have keen interest to synthesize inhibitor this conversion. From perspective, hybrid analogs imidazopyridine and oxadiazole ( 1–20 ) were designed efficiently synthesized followed characterizing them through varied spectroscopic methods 1 HNMR, 13 CNMR, HREI-MS). addition, vitro analyses compounds conducted evaluate their anti-urease potency. There was significant potential most analyzed, but 15 , 16, 17 (IC 50 = 2.20 ± 0.10 μM, IC 2.50 2.30 2.10 respectively) performed exceptionally well comparison with thiourea 22.30 0.44 μM). The selected candidates further investigated under molecular docking study confirm protein ligand interactions. energy gap E HOMO–LUMO explored via density functional theory studies.

Язык: Английский

Процитировано

11

Unveiling the chemistry of 1,3,4‐oxadiazoles and thiadiazols: A comprehensive review DOI Open Access
Vivek Kumar Gour,

Shaikh Yahya,

Mohammad Shahar Yar

и другие.

Archiv der Pharmazie, Год журнала: 2023, Номер 357(1)

Опубликована: Окт. 15, 2023

Abstract Oxadiazoles and thiadiazoles are malleable heterocycles that have recently generated major interest in the field of medicinal chemistry. Compounds based on these moieties versatile biological applications such as anticonvulsant, anticancer, antidiabetic, antioxidant agents. Due to nature stability oxadiazole thiadiazole nucleus, chemists changed structural elements ring numerous ways. These compounds shown significant anticonvulsant effects, demonstrating their potential management epileptic disorders. In this review, we covered pathways silico targeted proteins derivatives for treating various The data compiled article will be helpful researchers, research scientists, who work drug discovery development.

Язык: Английский

Процитировано

10

Construction of novel Mg Fe2O4/MgO composite: A high performer Photocatalyst for the cyclization of 1,3,4-oxadiazoles under Sunlight Irradiation DOI
Md. Afroz Bakht, Abdulrahman I. Alharthi, Mshari A. Alotaibi

и другие.

Journal of the Indian Chemical Society, Год журнала: 2025, Номер unknown, С. 101688 - 101688

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Identification of novel oxadiazole-based benzothiazole derivatives as potent inhibitors of α-glucosidase and urease: Synthesis, in vitro bio-evaluation and their in silico molecular docking study DOI Creative Commons
Yousaf Khan, Aneela Maalik, Wajid Rehman

и другие.

Journal of Saudi Chemical Society, Год журнала: 2023, Номер 27(4), С. 101682 - 101682

Опубликована: Июнь 26, 2023

This research work represents a synthetic approach for the development of hybrids derivatives oxadiazole-based benzothiazole (1-17) and diversity in was achieved using variety aryl ring S-substituted to see effect on biological activities. All synthesized were evaluated their vitro α-glucosidase urease inhibitory potential. The inhibition profile new moderate good potential with IC50 values ranging from 4.60 ± 1.20 µM 48.40 7.70 (α-glucosidase) 8.90 2.80 57.30 (urease) respectively. results compared standard acarbose (38.60 4.50 µM) thiourea (58.70 6.80 drugs Among series, analogs 1 having 4.60± (α-glucosidase), 2 5.60 1.60 10.90 2.10(urease) found be significantly active against targeted enzymes. structure all newly synthetics scaffolds confirmed by different types spectroscopic techniques such as HREI-MS, 1H- 13C- NMR spectroscopy. molecular docking studies showed correlations experimental findings. binding modes compounds interactions site residues revealed them possible anti-diabetics anti-urease leads. degree activity displayed novel innovative structural moieties make these leads promising candidates agents.

Язык: Английский

Процитировано

8

FeCl3-Catalyzed Synthesis of Symmetrical Pyridines from Ketoxime Acetates Using DMFDMA as an Effective C1 Synthon DOI

Rajitha Lakshmi Podugu,

Varaprasad Bodala,

Kumari Yettula

и другие.

Polycyclic aromatic compounds, Год журнала: 2023, Номер 44(7), С. 4455 - 4466

Опубликована: Сен. 7, 2023

AbstractAn efficient and facile strategy has been developed for the synthesis of symmetrical pyridines in good to excellent yields from ketoxime acetates DMFDMA presence FeCl3 at 120 °C 6 h under argon atmosphere. In this protocol, acts as an effective C1 synthon. The use inexpensive catalysts, no need additional ligands additives, functional group tolerance are perks protocol.Keywords: Symmetrical pyridinesDMFDMAoximeacetatesFeCl3C1 synthon AcknowledgmentsThe authors thank DST (Department Science & Technology), New Delhi funding through project EEQ/2021/000168.Disclosure statementNo potential conflict interest was reported by authors.

Язык: Английский

Процитировано

2